Microvast Holdings Inc

Microvast Holdings delivered a painful double miss in Q2 2024, with revenue of $83.67 million falling 9.39% short of the $92.35 million consensus and a non-GAAP loss of $0.21 per share coming in far worse than the $0.07 loss analysts had expected, a 200% negative surprise. Revenue did grow 11.6% year over year, aided in part by a reported 401% surge in EMEA sales, but the headline figures were overwhelmed by a $64.91 million impairment charge on long-lived assets, which ballooned total operating expenses to $103.56 million and widened the GAAP net loss to $78.44 million for the quarter. A bright spot was gross margin expansion to 32.5%, up sharply from 15.3% a year ago, signaling improving unit economics even as the bottom line deteriorated. Looking ahead, management guided Q3 2024 revenue of $85 million to $90 million, representing 6% to 12% year-over-year growth, though going concern risks and the need to raise additional capital remain key overhangs for investors.